Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia
Allergy2013Vol. 68(9), pp. 1177–1184
Citations Over TimeTop 12% of 2013 papers
Parameswaran Nair, Sergei I. Ochkur, Cheryl Protheroe, Katherine Radford, Ann Efthimiadis, N. A. Lee, J. J. Lee
Abstract
EPX-based ELISA is a valid, reliable, repeatable, and specific surrogate marker of eosinophils and/or eosinophil degranulation in the sputum of respiratory patients. The novel EPX assay is a valid and reproducible eosinophil-specific assay that can potentially be developed into a point-of-care assessment of eosinophil activity in airway secretions.
Related Papers
- → Increased Eosinophil Granule Proteins in Gut Lavage Fluid From Patients With Inflammatory Bowel Disease(1997)73 cited
- → Eosinophil peroxidase deficiency: morphological and immunocytochemical studies of the eosinophil-specific granules(1992)29 cited
- → Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis(1998)31 cited
- [Eosinophilic granulocytes and their significance in allergic diseases].(1992)
- → Eosinophil peroxidase deficiency: morphological and immunocytochemical studies of the eosinophil-specific granules(1992)2 cited